Buy & Sell Dominion Energy Inc (D) – Dominion Energy Inc Price Today
Aura AI Summary
Key Stats
- $59.52BMarket Cap
- UtilitiesSector
- -6.38%3M Drawdown
- $111.92BEnterprise Value
- 3.95%Dividend Yield
- 69 daysTypical Hold Time
Dominion Energy Inc (D) is currently valued at a market capitalization of $59.52B, with an enterprise value of $111.92B. Over the past 52 weeks, Dominion Energy Inc has traded between a low of $53.77 and a high of $68.29, highlighting its annual price range. Over the past three months, Dominion Energy Inc has recorded a drawdown of -6.38%, reflecting recent price volatility. Dominion Energy Inc offers a dividend yield of 3.95%, with the most recent dividend of $0.67 paid on 27 Feb 26. On average, investors hold Dominion Energy Inc for approximately 69 days, indicating typical investor behavior on the platform.
About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Most Recent News
CBAK Energy unveils advanced LFP cylindrical batteries boosting Southeast Asia's electric mobility.
CBAK Energy Technology showcased its innovative lithium-ion and sodium-ion cylindrical batteries designed for Southeast Asia's electric two- and three-wheelers at Autotech & Accessories 2026. Their batteries feature long life, high reliability, and s...

WeRide and Renault deploy autonomous Robobus at Roland-Garros for third year, expanding night service.
WeRide and Renault Group continue their partnership by operating the autonomous Robobus shuttle service at the Roland-Garros tennis tournament for the third consecutive year. The service runs a 2.8 km route connecting key points around the stadium, o...

Eli Lilly's gene therapy VERVE-102 cuts LDL cholesterol by up to 62% with lasting effects.
Eli Lilly reported positive Phase 1b results for VERVE-102, a gene therapy that permanently silences the PCSK9 gene to reduce LDL cholesterol by up to 62%. The therapy showed sustained effects for up to 18 months and was well-tolerated with no seriou...
